Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12.
Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12.
Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their..
Pfizer Says Trial Shows, COVID-19 Vaccine , Is Safe and Effective
for 5 to 11 Year-Olds.
On September 20, Pfizer said..